Frederick Beddingfield III insider trades: Sienna Biopharmaceuticals (SNNA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Frederick reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 22, 2019 | SNNA | ↑ Buy | 40,000 | $2.50 | $100K | Direct | Feb 26, 2019 (4d) |
| Sep 24, 2015 | KYTH | ↓ Sell | 110,638 | $74.91 | $8.3M | Direct | Sep 28, 2015 (4d) |
| Jun 25, 2015 | KYTH | ↓ Sell | 30,583 | $75.66 | $2.3M | Direct | Jun 25, 2015 (0d) |
| Apr 30, 2015 | KYTH | ↓ Sell | 2,041 | $45.51 | $93K | Direct | Apr 30, 2015 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Frederick Beddingfield III's insider trades
Frederick Beddingfield III is President & CEO at Sienna Biopharmaceuticals (SNNA). Since Apr 30, 2015, Frederick has reported 1 open-market purchase worth $100K and 3 sales worth $10.7M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (8 filings), shares withheld for taxes (4 filings), shares returned to the company (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SNNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.